BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4889075)

  • 1. [Clinical comparison of methophenazine and perphenazine in schizophrenia. A controlled study. Effects on the photomyoclonic threshold].
    Náhunek K; Svestka J; Misurec J
    Act Nerv Super (Praha); 1967 Nov; 9(4):404-5. PubMed ID: 4889075
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
    Náhunek K; Hádlík J; Rodová A; Misurec J; Vanýsek J
    Act Nerv Super (Praha); 1970 Jan; 12(1):56-7. PubMed ID: 4907390
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
    Svestka J; Náhunek K; Rodová A; Cesková E
    Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
    Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia.
    Rodová A; Náhunek K; Svestka J
    Act Nerv Super (Praha); 1971; 13(3):171-3. PubMed ID: 4939829
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controlled studies with thiothixene and perphenazine in schizophrenic psychoses].
    Hádlík J; Svestka J; Náhunek K; Rodová A
    Act Nerv Super (Praha); 1970 Jan; 12(1):60-1. PubMed ID: 4907392
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled comparison of clopenthixol and perphenazine in a chronic schizophrenic population.
    Dehnel LL; Vestre ND; Schiele BC
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):169-76. PubMed ID: 4967871
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical tests with proheptatrien in endogenous depressions. Influence on the photomyoclonic threshold].
    Náhunek K; Rodová A; Misurec J
    Cesk Psychiatr; 1967 Feb; 63(1):34-9. PubMed ID: 5343185
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
    Dis Nerv Syst; 1967 Jun; 28(6):369-83. PubMed ID: 5342391
    [No Abstract]   [Full Text] [Related]  

  • 12. Butaperazine (Repoise).
    Med Lett Drugs Ther; 1968 Nov; 10(22):89-90. PubMed ID: 4389275
    [No Abstract]   [Full Text] [Related]  

  • 13. An attempt to classify neuroleptic drugs on the basis of short-term clinical comparative studies.
    Rodová A; Náhunek K; Svestka J
    Act Nerv Super (Praha); 1974 Aug; 16(3):169-70. PubMed ID: 4609274
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipsychotic properties of loxapine succinate.
    Gershon S; Hekimian LJ; Burdock EI; Kim SS
    Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific therapeutic actions of acetophenazine, perphenazine, and benzquinamide in newly admitted schizophrenic patients.
    Hollister LE; Overall JE; Bennett JL; Kimbell I; Shelton J
    Clin Pharmacol Ther; 1967; 8(2):249-55. PubMed ID: 5336562
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical studies with clopenthixol (sordinol) on chronic psychiatric patients.
    Bartolucci G; Lehmann HE; Ban TA; Lee H
    Curr Ther Res Clin Exp; 1966 Dec; 8(12):581-4. PubMed ID: 4962727
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study).
    McLaughlin BE
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995
    [No Abstract]   [Full Text] [Related]  

  • 18. [Initial results of clinical trial of a new long-acting neuroleptic agent: Fluspirelene].
    Ciccarelli G; Nosè F
    Minerva Med; 1971 Dec; 62(98):4922-7. PubMed ID: 5141918
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
    Gayral LF; Escande MM; Fournie HC; Huron RJ
    Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the short-term therapeutic effect of oxyprothepine and perphenazine in schizophrenic patients. A controlled study.
    Svestka J; Rodovà A; Nàhunek K
    Act Nerv Super (Praha); 1973 May; 15(2):103-4. PubMed ID: 4591602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.